BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3910774)

  • 1. Treatment of essential hypertension with captopril in patients with chronic obstructive pulmonary disease.
    Bertoli L; Fusco M; Micallef E; Busnardo I
    J Hypertens Suppl; 1985 Nov; 3(2):S153-4. PubMed ID: 3910774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated.
    Bertoli L; Fusco M; Lo Cicero S; Micallef E; Busnardo I
    Postgrad Med J; 1986; 62 Suppl 1():47-51. PubMed ID: 3022273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of endralazine and captopril in essential hypertension: effect on renin levels, pulmonary function studies and lipid profile.
    Hauger-Klevene JH; Reader C; Mayer E; Sanchez MR
    Int J Clin Pharmacol Res; 1986; 6(4):275-81. PubMed ID: 3531038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of different beta-receptor blockers on the respiratory function of patients with chronic obstructive pulmonary disease and arterial hypertension].
    Dorow P
    Arzneimittelforschung; 1987 Dec; 37(12):1370-2. PubMed ID: 2896506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril in the treatment of hypertension associated with claudication.
    Libretti A; Catalano M
    Postgrad Med J; 1986; 62 Suppl 1():34-7. PubMed ID: 3534862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of captopril on pulmonary arterial hypertension in congestive heart failure associated with chronic obstructive bronchopneumopathy].
    Saadjian A; Philip-Joet F; Allard-Latour G; Arnaud A; Torresani J
    Rev Pneumol Clin; 1984; 40(5):321-5. PubMed ID: 6395282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Age dependence of the response of blood pressure, heart rate and plasma renin activity to captopril in essential hypertension].
    Stanek B; Silberbauer K
    Acta Med Austriaca; 1984; 11(3-4):101-5. PubMed ID: 6089491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy and safety of different beta-blockers in patients with isolated systolic hypertension associated with diabetes mellitus and obstructive pulmonary diseases].
    Kukes VG; Ostroumova OD; Mamaev VI; Batutina AM; Abakumov IuE; Zykova AA
    Ter Arkh; 2003; 75(8):43-7. PubMed ID: 14520850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-over comparison between captopril and nifedipine.
    Klein WW; Stuhlinger W; Mahr G
    Postgrad Med J; 1986; 62 Suppl 1():108-10. PubMed ID: 3317337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y; Poirier L; Provencher P
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S20-3. PubMed ID: 7522283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Continuous ambulatory monitoring of the therapeutic effect of captopril, 50 mg/day, in mild and moderate essential arterial hypertension].
    Hergueta G; Estruch J
    Rev Clin Esp; 1989 Mar; 184(4):174-6. PubMed ID: 2662270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and tolerability of the combination delapril plus indapamide in the treatment of mild to moderate essential hypertension: a randomised, multicentre, controlled study.
    Rosei EA; Rizzoni D;
    J Hum Hypertens; 2003 Feb; 17(2):139-46. PubMed ID: 12574793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease: position of vasodilators with special focus on urapidil.
    Adnot S; Samoyeau R; Weitzenblum E
    Blood Press Suppl; 1995; 3():47-57. PubMed ID: 8535542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [24-Hour arterial pressure profile in chronic obstructive lung diseases in combination with arterial hypertension treated with enalapril].
    Ol'binskaia LI; Belov AA
    Ter Arkh; 2002; 74(3):59-62. PubMed ID: 11980126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of captopril on hemodynamics in patients of chronic obstructive pulmonary disease with pulmonary hypertension].
    Wang S
    Zhonghua Nei Ke Za Zhi; 1993 Aug; 32(8):545-8. PubMed ID: 8269786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in the treatment of moderate to severe hypertension.
    Kaul UA; Chutani SK; Verma IC; Khalilullah M
    J Assoc Physicians India; 1989 Feb; 37(2):152-4. PubMed ID: 2681137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ramipril vs captopril in mild to moderate hypertension.
    Yajnik VH; Vatsraj DJ; Acharya HK; Yajnik NV; Vyas NR; Vakil HB
    J Assoc Physicians India; 1994 Feb; 42(2):120-3. PubMed ID: 7860471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.